← Dashboard Aug 12, 2026 07:27 AM ET

CatalystFDA/Bio

Revolution Medicines (RVMD) Is Up 6.2% After BeOne-Funded Phase 3 RAS(ON) Deal - Has The Bull Case Changed?

6.2

What changed

Why it matters

6.2

Sources

Related signals

PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →

© 2026 StockDuty · Disclaimer · Terms · Privacy · Support

For informational and educational purposes only. Stock Duty provides impersonal investment research and market intelligence, not personalized investment advice. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult a qualified financial professional before making investment decisions. Stock Duty and its contributors may hold positions in securities discussed.